Development and verification of the PAM50-based Prosigna breast cancer gene signature assay-Reference-Cited by-同舟云学术

Development and verification of the PAM50-based Prosigna breast cancer gene signature assay

Published:2015-08-22 Issue:1 Volume:8 Page:
ISSN:1755-8794
Container-title:BMC Medical Genomics
language:en
Short-container-title:BMC Med Genomics

Author:

Wallden Brett,Storhoff James,Nielsen Torsten,Dowidar Naeem,Schaper Carl,Ferree Sean,Liu Shuzhen,Leung Samuel,Geiss Gary,Snider Jacqueline,Vickery Tammi,Davies Sherri R.,Mardis Elaine R.,Gnant Michael,Sestak Ivana,Ellis Matthew J.,Perou Charles M.,Bernard Philip S.,Parker Joel S.

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Genetics

Link

http://link.springer.com/content/pdf/10.1186/s12920-015-0129-6.pdf

Reference56 articles.

1. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869–74.

2. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A. 2003;100(14):8418–23.

3. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics. 2006;7:96.

4. Nielsen TO, Parker JS, Leung S, Voduc D, Ebbert M, Vickery T, et al. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Clin Cancer Res. 2010;16(21):5222–32.

5. Chia SK, Bramwell VH, Tu D, Shepherd LE, Jiang S, Vickery T, et al. A 50-gene intrinsic subtype classifier for prognosis and prediction of benefit from adjuvant tamoxifen. Clin Cancer Res. 2012;18(16):4465–72.

Cited by 387 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma;Surgical Clinics of North America;2024-10

2. Prosigna Assay for Treatment Decisions in Early Breast Cancer: A Decision Impact Study;Journal of Clinical Medicine;2024-09-09

3. Elevated expression of Aurora-A/AURKA in breast cancer associates with younger age and aggressive features;Breast Cancer Research;2024-08-28

4. Obtention of viable cell suspensions from breast cancer tumor biopsies for 3D chromatin conformation and single-cell transcriptome analysis;Frontiers in Molecular Biosciences;2024-08-22

5. Validation of an AI-based solution for breast cancer risk stratification using routine digital histopathology images;Breast Cancer Research;2024-08-14